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103Ten-year technical and clinical outcomes in
TransAtlantic Inter-Society Consensus II
infrainguinal C/D lesions using duplex ultrasound
arterial mapping as the sole imaging modality for
critical lower limb ischemia
Sherif Sultan, MCh, MD, FRCS, EBQS/Vasc, FACS,a,b Wael Tawﬁck, MRCSI,a and
Niamh Hynes, MD, MRCSI, MMSc,b Galway, Ireland
Objective: The aim of this study was to evaluate duplex ultrasound arterial mapping (DUAM) as the sole imaging modality
when planning for bypass surgery (BS) and endovascular revascularization (EvR) in patients with critical limb ischemia
for TransAtlantic Inter-Society Consensus (TASC) II C/D infrainguinal lesions.
Methods: This was a retrospective review evaluating the accuracy of DUAM as the sole imaging tool in determining patient
suitability for BS vs EvR. Primary outcomes were the sensitivity and speciﬁcity of DUAM compared with intraoperative
digital subtraction angiography. Secondary outcomes were procedural, hemodynamic, and clinical outcomes, amputation-
free survival, and freedom from major adverse clinical events.
Results: From 2002 to 2012, a total of 4783 patients with peripheral arterial disease were referred, of whom 622 critical
limb ischemia patients underwent revascularization for TASC C and D lesions (EvR: n [ 423; BS: n [ 199). Seventy-
four percent of EvR and 82% of BS were performed for TASC D (P[ .218). The DUAM showed sensitivity of 97% and
speciﬁcity of 98% in identifying lesions requiring intervention. Of the 520 procedures performed with DUAM alone,
there was no difference regarding the number of procedures performed for occlusive or de novo lesions (EvR: 65% and
71%; BS: 87% and 78%; P[ .056). Immediate clinical improvement to the Rutherford category #3 was 96% for EvR and
97% for BS (P[ .78). Hemodynamic success was 79% for EvR and 77% for BS (P[ .72). Six-year freedom from binary
restenosis was 71.6% for EvR and 67.4% for BS (P [ .724). Six-year freedom from target lesion revascularization was
81.1% for EvR and 70.3% for BS (P[ .3571). Six-year sustained clinical improvement was 79.5% for EvR and 66.7% for
BS (P [ .294). Six-year amputation-free survival was 77.2% for EvR and 74.6% for BS (P [ .837). There was
a signiﬁcant difference in risk of major adverse clinical events between EvR and BS (51% vs 70%; P[ .034). Only 16.4% of
patients required magnetic resonance angiography, which tended to overestimate lesions with 84% agreement with
intraoperative ﬁndings. Six-year binary restenosis was 71% for DUAM procedures compared with 55% for magnetic
resonance angiography procedures (P [ .001), which was solely based on the prospective modality.
Conclusions: The DUAM epitomizes a minimally invasive, economically proﬁcient modality for road mapping procedural
outcome in BS and EvR. It allows for high patient turnover with procedural and clinical success without compromising
hemodynamic outcome. The DUAM is superior to other available modalities as the sole preoperative imaging tool in
a successful limb salvage program. (J Vasc Surg 2013;57:1038-45.)Peripheral vascular disease (PVD) affects 10% of the
population, and the incidence increases to 25% in the pop-
ulation older than 70 years.1-4 Due to the vulnerability and
high comorbidities of the elderly population, there has
been a major shift toward minimally invasive endovascularthe Western Vascular Institute, Department of Vascular and Endovas-
lar Surgery, Galway University Hospitala; and the Department of
ascular and Endovascular Surgery, Galway Clinic.b
or conﬂict of interest: none.
ented at the 2012 Vascular Annual Meeting of the Society of Vascular
rgery, Washington, DC, June 7-9, 2012.
rint requests: Dr Sherif Sultan, Western Vascular Institute, Department
Vascular & Endovascular Surgery, Block 2C, Galway University
ospital, Newcastle Road, Galway, Ireland (e-mail: sherif.sultan@hse.ie).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2013 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2012.10.005
8techniques for the management of PVD. Endovascular
revascularization (EvR) has been shown to be an effective
modality for PVD treatment, with outcomes comparable
with those of reconstructive bypass vascular surgery
(BS).1-3 The concept of a minimally invasive approach to
the management of PVD patients should be accompanied
by noninvasive imaging modalities for preoperative arterial
mapping.
Digital subtraction angiography (DSA) has been consi-
dered for many years the gold standard for preoperative
identiﬁcation of arterial lesions.5-8 However, DSA is an
invasive technique associated with signiﬁcant local and syst-
emic complications, including hematomas, arterial damage,
systemic anaphylaxis, and renal failure.7,9-11 Less invasive
imaging modalities, such as computed tomography angiog-
raphy, magnetic resonance angiography (MRA), and nonin-
vasive duplex ultrasound arterial mapping (DUAM), offer an
alternative to DSA.
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proper treatment selection from the diversity of procedures
available for each individual pathology.3 The appropriate
choice of intervention can only be made based on adequate
and clear preoperative arterial mapping that accurately delin-
eates the diseased arterial tree.3 This brings to the fore not
only the invasiveness of the preoperative arterial mapping
modality but also its sensitivity and speciﬁcity in accurately
determining the characteristics of the arterial lesion.
The DUAM has been shown to be an effective means of
direct, noninvasive evaluation of arterial disease that can
accurately discriminate between occluded, stenotic, and
healthy vessels. However, DUAM is operator dependent,
with some risk of interobserver discrepancy. Based on these
limitations, DUAM has been used as an adjunct to other
arterial mapping modalities. The aim of this study was to
evaluateDUAMas the sole imagingmodalitywhen planning
for BS and EvR in patients with critical limb ischemia (CLI)
for TransAtlantic Inter-Society Consensus (TASC II) C/D
lesions in infrainguinal lesions.
The primary end points were the sensitivity and speci-
ﬁcity of DUAM in picking up arterial lesions adequately,
thus allowing for appropriate procedure selection. The
sensitivity and speciﬁcity are validated against intraopera-
tive DSA for EvR and BS procedures, supplemented by
intraoperative visual ﬁndings in BS.
The secondary end points were as follows. Clinical
outcomes were immediate clinical improvement and sus-
tained clinical improvement, deﬁned as cumulative improve-
ment of $2 classes according to Rutherford et al12 and/
or minimal hemodynamic improvement (ankle-brachial
index [ABI] >0.15) without the need for repeated target
lesion revascularization (TLR) in surviving patients and
amputation-free survival. Hemodynamic outcomes were
improvement of ABI by $0.15. Procedural outcomes were
binary restenosis as assessed by duplex ultrasound scanning,
deﬁned as a peak velocity ratio>2.4 at the target lesion, and
calculated within a cumulative analysis. In patients with
multilevel disease, binary restenosis was deemed to have
occurred if any of the treated lesions had restenosed to
50%. The TLRwas calculated for all treated lesions. Freedom
from major adverse clinical events was deﬁned as any of the
following clinical events within the ﬁrst 30 days: limb loss,
myocardial infarction, congestive heart failure, renal failure
requiring dialysis, respiratory event requiring ventilation,
wound complications requiring reintervention, or thrombo-
embolism requiring treatment. This is in addition to any of
the following events at any time: mortality, need for TLR,
or need for target extremity revascularization
SUBGROUP ANALYSIS
A subgroup of patients in whom infragenicular
calciﬁcation prohibited accurate DUAM underwent an
additional MRA examination, and the sensitivity and spec-
iﬁcity of MRA in detecting lesions were also compared
with that of intraoperative DSA in these EvR and BS
procedures.METHODS
CLI was deﬁned according to the Society of Vascular
Surgery reporting standards.12 All patients with CLI
underwent duplex ultrasound scanning, and patients who
were deemed to have no option for revascularization, either
for anatomic or comorbid reasons, were started on
a sequential compression device program.13
Duplex ultrasound arterial mapping was used as the
primary preoperative arterial mapping modality. Magnetic
resonance imaging was used only in cases where DUAM
was inconclusive due to heavy calciﬁcation. Preprocedural
imaging identiﬁed lesions according to localization by
TASC II classiﬁcation of lesion type (C/D).
The objective of this study was to examine the validity
of a DUAM-only policy for planning revascularization
procedures in critically ischemic limbs with TASC C and
D femoropopliteal disease. However, as expected with crit-
ically ischemic limbs, many patients had multilevel disease.
All levels of disease were scanned, and hemodynamically
signiﬁcant lesions were treated. All patients are brought
to surgery on an intention-to-treat basis, and although
femoropopliteal disease was the primary treatment target,
inﬂow and outﬂow disease were also treated to ensure
straight line ﬂow to the foot.
Imaging. The DUAM was performed and reported by
accredited vascular scientists in the vascular laboratory
using an ATL HDI 5000 (Philips International BV,
Amsterdam, The Netherlands) or an IU22 scanner (Philips
International BV). All of the vascular scientists are regis-
tered members of the Society for Vascular Technology of
Great Britain and Ireland who have attained and main-
tained registration in accordance with society guidelines,
as set out in the Society for Vascular Technology of Great
Britain and Ireland accreditation document.14
The patient is examined supine with the legs at the
level of the heart using imaging and Doppler carrier
frequency of 3.5 to 10 MHz. The arterial tree is assessed
using B-mode, spectral analysis, and color Doppler imaging
from the aortoiliac segment in continuity through to and
including the tibial vessels and into the foot. The arteries
are assessed for the presence or absence of ﬂow. When
ﬂow is present, evaluation is undertaken of peak systolic
velocity (PSV), end-diastolic velocity, and waveform anal-
ysis (eg, systolic upstroke/acceleration, pulsatility, spectral
broadening, turbulence, and ﬂow direction) as required.
Spectral analysis is obtained for all vessel segments as well
as proximal, throughout, and distal to any region where
ﬂow disturbance is identiﬁed. All Doppler-derived velocity
information is performed at an angle #60 degrees relative
to the direction of blood ﬂow, and Doppler cursor align-
ment is parallel to the arterial walls. For identiﬁed lesions,
the arterial size, the length and degree of stenosis based
on PSV ratios, and plaque characteristics are noted. All
signiﬁcant lesions are marked on the skin.
DUAM technical considerations. Hemodynamic
stenosis >50% is correlated with spectral broadening,
a monophasic waveform, and doubling of the ratio of
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the lesion. A 75% stenosis quadruples the PSV ratio,
whereas a 90% stenosis increases the PSV ratio sevenfold.
A severe critical stenosis is always associated with low veloc-
ities distally.15
In the case of inability to see the proximal aortoiliac
segment, an acceleration time <100 ms rules out a signiﬁ-
cant proximal stenosis. We routinely use a 3- to 5-MHz
transducer for adequate penetration in order to visualize
deep vessels in the aortoiliac segment. In very obese
patients, the frequency of the transducer can be adjusted,
and the probe can be pressed into the ﬂesh as required.
The iliac veins and the inferior vena cava are our landmarks
in the case of occlusion of the aortoiliac segment. A 5- to
10-MHz transducer is used for femorodistal segment
imaging. Leg dependence helps in imaging the occluded
tibial vessels by ﬁlling the adjacent veins. Collaterals that
reconstitute a main vessel are landmarks to determine
extent of occlusion.
When multiple lesions are present along the arterial
tree, each one subtracts from the velocity of the subsequent
lesion. Bear in mind that multiple lesions can lead into
very-low-ﬂow status, which should not be mistaken for
an occlusion.
Lesions within the adductor canal can be overcome by
appropriate positioning of the patient. The presence of
casts or orthopedic implants can impede DUAM, but
none of these limitations was seen in the current study
population.
The main purpose of DUAM is not to mimic DSA but
to provide information for a successful revascularization.
The decision regarding choice of procedure was based
on details of the inﬂow and adequacy of the outﬂow. The
patient was scheduled for EvR unless the following charac-
teristics were present: (1) Echolucency of the plaque, where
the plaque appeared black and had a consistency similar to
blood. This indicated fresh thrombus was present in the
lesion, requiring treatment. In this case, the risk of emboli-
zation and trashing would be high if a wire was passed
through the thrombus when performing an endovascular
intervention, so an endovascular option was abandoned in
favor of BS. (2) Such extensive heavy calciﬁcation that power
duplex ultrasound scanning cannot delineate the arterial
tree. In the case where the plaque appears to be heavily calci-
ﬁed on duplex ultrasound scanning, EvR would not be the
procedure of choice because it is extremely difﬁcult to pass
a guidewire through such a hard plaque or to form a subinti-
mal plane. (3) Flush occlusions where no gap was present
between the ostium of the superﬁcial femoral artery and
the beginning of the lesion. In the case where the lesion is
ﬂush with the takeoff of the superﬁcial femoral artery, a sub-
intimal angioplasty can be difﬁcult because it is hard to gain
entry to the subintimal plane without a nipple. Furthermore,
in this situation, there is an added risk of obliterating the
ostium of the profunda femoris artery.
Magnetic resonance imaging technicians using a 1.5-
Tesla whole-body magnetic resonance imaging scanner with
gadolinium enhancement performed theMRA. A radiologistwho was not involved in the procedure planning or interven-
tion reported the images.
Follow-up. Patients were followed up postoperatively
at day 1, week 6, and 3 months and every 6 months
thereafter according to our standard follow-up protocol,
which was previously published.16-18 The ABI, digital
pressures, and duplex ultrasound scanning of the lower
limb were carried out to assess for hemodynamic success
and binary restenosis according to the Society of Vascular
Surgery reporting standards.12
Statistical analysis. This is a retrospective review of
data that were prospectively collected into a dedicated
vascular database (Vascubase 5.8; Consensus Medical,
Vancouver, Canada). Statistical analysis was performed
using IBM SPSS (version 18; SPSS Inc, Chicago, Ill). Scale
data were analyzed using independent t-test or Mann-
Whitney U test where appropriate. Categorical data were
analyzed with c2 or Fisher exact test where appropriate.
Kaplan-Meier analysis with log-rank was used for survival
time analysis.
RESULTS
From 2002 to 2012, a total of 4783 patients with PVD
were referred. Of these patients, 622 underwent revascular-
ization for TASC C and D lesions for infrainguinal PVD
(EvR: n ¼ 423; BS: n ¼ 199). The DUAM was used alone
for preoperative mapping in 520 patients (83.6% of proce-
dures), whereas DUAM was supplemented by MRA in
102 patients. All patients went to surgery on an intention-
to-treat basis with an option for conversion to open or endo-
vascular repair if on-table angiography was inconsistent with
DUAM. However, no patient crossed over from open to
endovascular revascularization, or vice versa.
DUAM alone. Looking at the 520 procedures per-
formed based on DUAM alone, there was no signiﬁcant
difference in demographics between the two operative
groups (Table I). Clinical presentation and lesion charac-
teristics were all similar between the two groups (Table II).
Comparing the lesion pickup rate and accurate descrip-
tion of lesion ﬁndings with intraoperative DSA or intrao-
perative visualization, to those picked up by duplex
ultrasound scanning, DUAM showed a sensitivity of 97%
and a speciﬁcity of 98% in identifying the number of lesions
requiring intervention. The DUAM identiﬁed 769 lesions
that required intervention. Of these, 746 were identiﬁed
intraoperatively and treated. Sixteen lesions that were not
detected by DUAM, all in the EvR group, were identiﬁed
intraoperatively and required treatment.
Immediate clinical improvement was comparable in
both operative groups (performed based on DUAM
alone), with improvement to Rutherford category #3 of
96% for EvR and 97% for BS (P ¼ .78). Hemodynamic
success was 79% in EvR and 77% in BS (P ¼ .72;
Table III).
In procedures performedbasedonDUAM, therewas no
signiﬁcant discrepancy in procedural outcomes between the
two operative groups. Six-year freedom frombinary resteno-
sis was 71.6% for EvR and 67.4% for BS (P ¼ .724; hazard
Table II. Clinical and anatomic presentation
EvR BS P value
Procedures based on DUAM 367 153 —
Rutherford category 4 39% 46% .615
Rutherford category 5 49% 41% —
Rutherford category 6 12% 13% —
TASC D 74% 82% .218
Occlusive lesions 65% 87% .056
De novo lesions 71% 78% .537
BS, Bypass surgery; DUAM, duplex ultrasound arterial mapping; EvR, endo-
vascular revascularization; TASC, TransAtlantic Inter-Society Consensus.
Table III. Immediate clinical improvement
EvR BS P value
Improvement to Rutherford category #3 96% 97% .78
Hemodynamic success (ABI improved
by $0.15)
79% 77% .72
ABI, Ankle-brachial index; BS, bypass surgery; EvR, endovascular
revascularization.
Table I. Demographics
EvR BS P value
Number of patients 423 199 —
Age, yearsa 73 (613) 70 (614) .371
Gender, male 45% 65% .084
Hypertension 69% 62% .231
Hyperlipidemia 78% 77% .311
Diabetes mellitus 82% 77% .276
Smoking 90% 87% .317
Ischemic heart disease 34% 37% .106
Renal insufﬁciencyb 24% 26% .398
Homocysteinec 12.9 13.6 .254
Hemoglobin A1C
c 5.9 6.2 .418
Fibrinogenc 5.6 5.8 .406
BS, Bypass surgery; EvR, endovascular revascularization.
aMean (standard deviation).
bCreatinine >2.0 mg/dL.
cHomocysteine is measured in mmol/L; hemoglobin A1c is measured as
a percentage (%) of total hemoglobin; and ﬁbrinogren is measured as g/L.
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1.98; Fig 1). Six-year freedom from TLR was 81.1% for
EvR and 70.3% for BS (P ¼ .3571; HR, 0.64; 95%
CI, 0.12 to 1.49; Fig 2).
Long-term clinical outcomes were comparable in both
treatment groups based on DUAM. Six-year sustained clin-
ical improvement was 79.5% for EvR and 66.7% for BS
(P ¼ .294; HR, 0.69; 95% CI, 0.18 to 1.81; Fig 3).
Six-year amputation-free survival was 77.2% for EvR and
74.6% for BS (P ¼ .837; HR, 0.92; 95% CI, 0.42 to
1.99; Fig 4). There was, however, a signiﬁcant difference
in risk of major adverse clinical events between EvR and
BS (51% vs 70%; P ¼ .034; Fig 5).
DUAM vs MRA. When comparing the intraoperative
ﬁndings to MRA, MRA had a tendency to overestimate
lesions requiring intervention and showed only 84% agree-
ment with intraoperative ﬁndings. The MRA detected 240
lesions requiring intervention; however, only 201 were
actually treated.
Taking into account machine maintenance and per-
sonnel time, the mean cost of performing DUAM is
V65, whereas the mean cost of performing MRA is V415.
DISCUSSION
Contemporary studies on lower limb endovascular
therapy primarily focus on technical and clinical outcomes.
Consequently, there is a paucity of data on diagnostic tools
and cost-effectiveness, which seems somewhat remiss, espe-
cially in a population overburdened with comorbidities and
a limited life expectancy that obscure the line between
treatment risks and beneﬁts.
Davies et al19 reported that DUAM shows sensitivity
and speciﬁcity of 100%. Legemate et al20 found that in
the femoropopliteal segment, DUAM demonstrated 90%
sensitivity and 98% speciﬁcity compared with DSA. These
results are in keeping with our outcome, where DUAM
showed a sensitivity of 97% and a speciﬁcity of 98%. Inour experience, DUAM rarely underestimated or overesti-
mated lesions requiring intervention.
However, our results depicted that MRA overestimated
lesions requiring intervention. Sixteen percent of lesions
identiﬁed by MRA were found to not warrant intervention
according to the intraoperative ﬁndings. These ﬁndings
were conﬁrmed by the results of Soule et al,21 who also
noted an overestimation of MRA-detected lesions.
MRA has been considered a promising noninvasive arte-
rial mapping tool, albeit expensive.22-25 However, the risk of
gadolinium toxicity as well as the patients’ clinical limita-
tions in using this modality21-26 expose the narrow spectrum
of patients on whom an MRA can be used. In our study,
none of the patients experienced gadolinium toxicity;
however, nine patients had suboptimal MRA imaging of
the infragenicular vessels due to venous contamination.
Furthermore, ﬁve patients could not complete the scanning
procedure due to claustrophobia and were excluded from
the study.
Certain lesion characteristics are more readily identiﬁed
by DUAM than MRA.16 The DUAM is able to provide
information on echolucency, which is considered a contra-
indication to EvR due to the risk of distal embolization. At
the other end of the spectrum, DUAM identiﬁes heavily
calciﬁc plaques, thus rendering EvR an unfeasible
approach. Currently, our protocol of assigning a patient
to either EvR or BS is based on plaque echolucency and
morphology.17,18 We believe that the improved outcome
of procedures performed based on DUAM can be attrib-
uted to the appropriate choice of intervention, where no
EvR was performed for echolucent or heavily calciﬁed
lesions, and these patients had primary bypass.27
For the procedures performed based on duplex
mapping alone, we did not experience any signiﬁcant
discrepancies between BS and EvR with regard to
Fig 1. Binary restenosis. BS, Bypass surgery; EVR, endovascular revascularization.
Fig 2. Target lesion revascularization. BS, Bypass surgery; EVR,
endovascular revascularization.
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vention groups had outcomes that were as favorable as
any of those reported in the literature, even in the context
of the most severe TASC II C and D lesions.28 This
demonstrates that our procedure choice, as predicted by
DUAM, was correct. We did document a signiﬁcant reduc-
tion in major adverse clinical events in the EvR compared
with the BS group. However, this could be attributable
to the more invasive nature of BS.
The DUAM can provide information on the vessel
wall, plaque morphology and echolucency, and luminal
and turbulent ﬂow, which can be difﬁcult to assess by other
imaging modalities.29 This can directly inﬂuence the
outcome of procedures if based on MRA alone, especially
in cases where EvR was performed after failure to identify
echolucent lesions.
Other authors have reported results similar to ours,
demonstrating that DUAM permits the design of medical,
surgical, or endovascular treatment plans with a high level
of concurrence with the ﬁndings acquired during the revas-
cularization procedure.30-32
The fact that an adequate outcome depends on the
experience of the vascular scientists cannot be overlooked.
Limited visualization of the crural vessels, especially in thepresence of calciﬁcation, is a common occurrence.29 In our
study, most of the lesions that were not detected by
DUAM but were identiﬁed intraoperatively were located
in the crural vessels. However, this did not inﬂuence the
procedural or clinical outcome of these patients.
Our experience mirrors the ﬁnding of Eiberg et al33
that DUAM is a superior option technique for imaging
the distal crural arteries in CLI patients and is not affected
by the severity of peripheral arterial disease. Moreover, it
provides a functional noninvasive substitute to DSA.
The beneﬁts of high sensitivity and speciﬁcity of lesion
detection as well as the beneﬁts of being a noninvasive
modality should be weighed against the experience of the
vascular technologist. The DUAM can be used as the
sole preoperative mapping modality in a proper vascular
laboratory setup, where scientists have direct access to the
operating room, where they can compare their ﬁndings
with the intraoperative lesions and improve their under-
standing of the procedure performed.
However, the Schroeder group in Denmark empha-
sized that the panacea of DUAM operator dependency
can be overcome.34 They studied a physician inexperienced
with DUAM who performed 100 DUAMs in 100 consec-
utive limbs, 74% of which had CLI and compared the
DUAM ﬁndings to DSA. The number of insufﬁciently
insonated segments (nondiagnostic segments) was signiﬁ-
cantly reduced during the study, from 9% among the initial
50 limbs to 2% among the last 50 limbs (P < .0001). This
improvement was evident only in the infragenicular
segments, as the performance within the supragenicular
segments was good from the beginning. They concluded
that the minimum training requirement for competency
in DUAM is relatively low, with 15 examinations for
the supragenicular segments and 50 examinations for infra-
genicular segments. The DUAM is a reliable technique, is
reproducible, and is easy to learn.
We concur with the proposal by Tinder et al35 that
use of duplex surveillance for higher-risk revascularized
patients, regardless of whether they are treated by BS or
EvR, necessitates enhanced protocols, rigorous surveillance,
Fig 3. Sustained clinical improvement. BS, Bypass surgery; EVR, endovascular revascularization.
Fig 4. Amputation-free survival. BS, Bypass surgery; EVR, endo-
vascular revascularization.
Fig 5. Freedom from major adverse clinical events (MACE). BS,
Bypass surgery; EVR, endovascular revascularization.
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symptomatic patients. Such stringent surveillance pathways
within our clinical practice certainly contributed to our
favorable TLR and TER results in this study. Our clinical
surveillance programs are not in place with the sole purpose
of examining the treated lesions. We take the opportunity at
each clinical visit to ensure wound healing, the patient’s
compliance with medication, absence from tobacco use,
and general lifestyle adjustments. Appropriate serologic tests
are performed, and in our diabetic population, care is also
taken to check feet for new wounds and ensure good
glucose control. An experienced vascular advanced nurse
practitioner service, which counsels patients and liaises
with allied health professionals, ensures that we canmaintain
good access to services and maintain a high quality of care.
The Diagnostic Imaging of Peripheral Arterial Disease
trial is 10 years old and is completely out of context for
contemporary vascular practice.35 In 2001, when the Diag-
nostic Imaging of Peripheral Arterial Disease trial was initi-
ated, technology, learning curves, and minimal invasive
diagnostics were at their infancy. The authors concluded
that MRA provides a precise road map for planning treat-
ment, whereas DUAM provides for more subjective inter-
pretation of data on a schematic drawing. In the context of
this trial, physicians had higher therapeutic conﬁdence in
MRA and requested additional vascular imaging after
DUAM. From our own experience, we required additionalimaging in only 16% of cases; however, only 7% of MRA
added extra details but did not affect clinical decision-
making.
Our results contradict the ﬁnding of Ouwendijk et al36
that DUAM is more expensive than MRA. Our ﬁndings
give clinical context to the computerized model designed
by Cofﬁ et al,37 which predicted that a DUAM-ﬁrst
strategy was cost effective in patients with PVD.
De Vries et al38 conﬁrmed that substituting duplex
ultrasound scanning with contrast-enhanced MRA for the
initial imaging workup of patients with peripheral arterial
disease escalates the diagnostic costs. The fact that the
authors of the later paper were co-authors on the Diagnostic
Imaging of Peripheral Arterial Disease trial testiﬁes to the
paradigm shift toward DUAM in contemporary practice.
The limitations of this study are that it was not
prospective, randomized, or controlled. However, the
methodology did allow for clinical audit of a large volume
of patients with severe disease and justiﬁes DUAM’s
primary role within a successful high-volume limb salvage
program.
The future lies with the clinical application of three-
dimensional reconstructed lower limb vessel imaging with
duplex ultrasound robotic systems, which might be proven
to override the human error factor in bedside high-
deﬁnition vascular imaging.39
CONCLUSIONS
The DUAM allows for consistently accurate results
with minimal cost, and its noninvasiveness makes it very
JOURNAL OF VASCULAR SURGERY
1044 Sultan et al April 2013attractive to patients. The steep learning curve with this
imaging modality means that these practices can be readily
introduced into other vascular surgery units and as such
makes it very interesting for the vascular community in
general.
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